Kholoud Porter
机构: University College London
每年引用次数
引用次数
引用: 12,988
H-指数: 61
I10-指数 : 172
出版物: 343
Effect of transient antiretroviral treatment during acute HIV infection: comparison of the Quest trial results with CASCADE natural history study.
Kaldor J , Porter K , Lampe Fc , Phillips An
Antiviral Therapy 12 ( 2) 189 -193
24
2007
Travel, heterosexual intercourse and HIV-1 infection.
Gill On , Porter K , Clarke Se , Noone A
CDR (Lond Engl Rev) , 1 (4) R39-R43. (1991) 1 ( 4)
11
1991
Health care workers and HIV: surveillance of occupationally acquired infection in the United Kingdom.
Black Mb , Porter K , Heptonstall J , Gilbart Vl
Communicable disease report. CDR review 3 ( 11)
20
1993
Differences in Time to Virological Failure, Treatment Changes and Cessation between Persons Treated Soon after HIV Seroconversion and in Chronic Infection
D Zugna , K Porter , R Geskus , A Babiker
Epidemiologia & Prevenzione 34 154 -154
2010
Incidence of transmitted anti-retroviral drug resistant HIV may be rising in the UK
UK Register Hiv Seroconverter , Phls Antiviral Susceptibility Ref , GL Dean , MJ Fisher
AIDS , 14 S122 - S122. (2000)
2000
Setting up a Standardized Peripheral Blood Mononuclear Cells (PBMCs) Processing Laboratory in a field site in rural Uganda to support multi-centre HIV/AIDS vaccine and intervention trials: Experience from Design to Functionality
E Ruzagira , D Admassu , A Kamali , T Khamis
Lab Medicine , 42 (12) pp. 1-8. (2011)
2011
The effect of HCV infection duration on HIV disease progression
C Leen , J Inshaw , S Fidler , K Porter
2014
HIV-infected individuals co-infected with hepatitis C appear to have faster CD4 decline in the absence of ART but similar response once combination ART is initiated.
F Ewings , A Copas , S Fidler , K McLean
Presented at: 16th Conference on Retroviruses and Opportunistic Infections, Montreal. (2009)
2009
Authors' response to Drs Scourfield, Jackson and Nelson
L Waters , M Fisher , J Anderson , C Wood
Hiv Medicine 12 ( 7) 450 -451
2011
CD4 cell count and starting ART: trends in six UK centres 1997 – 2002.
W Stöhr , D Dunn , K Porter , C Sabin
Presented at: 11th Annual Conference of the British HIV Association with the British Association for Sexual Health and HIV (BASHH), Dublin, Ireland. (2005)
2005
Prevalence of atypical mutations at codon 215 of HIV-1 reverse transcriptase
Y Rehman , P Cane , K Porter , D Pillay
In: ANTIVIR THER. (pp. S60 - S60). INT MEDICAL PRESS LTD (2002)
2002
The AIDS incubation period in the UK estimated from a national register of HIV seroconverters
A Pozniak , V Beral , K Porter , A N Phillips
AIDS 12 659 -667
32
1998
Response to news that an obstetrician/gynaecologist has AIDS.
Hochuli , K Porter , O Hyndman
Communicable disease report. CDR review 5 ( 1)
2
1995
Evidence for rising prevalence of HIV-1 drug resistance in primary infections in the UK
G Dean , M Fisher , P Cane , K Porter
BMJ , 322 pp. 1087-1088. (2001)
2001
The impact of transmitted drug resistance on time to CD4 < 350 cells/ml
G Dean , UK Register Hiv Seroconverters , M Fisher , P Cane
ANTIVIR THER , 7 S192 - S192. (2002)
2002
Incidence of Kaposi's Sarcoma and survival following its diagnosis in HIV-infected homosexual men followed up since HIV seroconversion
S Lodi , M Guiguet , D Costagliola , M Fisher
Journal of National Cancer Institute , 102 (11) pp. 784-792. (2010)
2010
Quarterly Communicable Disease Review January to March 1994 from the PHLS Communicable Disease Surveillance Centre
D Bennett , K Porter , D Kumar , M Brett
J Public Health , 16 (3) pp. 357-364. (1994)
1994
Impact of timing of ART on HIV DNA; findings from HEATHER, an observational cohort study
N Nwokolo , S Fidler , J Thornhill , K Kuldanek
Hiv Medicine 17 11 -11
2016
Altruism and medical advice are key factors in decision-making about participating in HIV cure research: Results from a UK-wide survey of people living with HIV
S Fidler , K Porter , S Collins , S Taylor
HIV MEDICINE , 16 pp. 62-63. (2015)
1
2015
Patterns of decrease in CD4 cell count after seroconversion: comparison between Beijing PRIMO cohort and CASCADE seroconverter cohorts
K Porter , Z Fox , XN Xu , XJ Huang
In: INT J INFECT DIS. (pp. S36 - S37). ELSEVIER SCI LTD (2011)
2011